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Abstract
Despite many differences between Traditional Chi-
nese Medicine (TCM) and conventional medicine,
the use of TCM in the treatment of human immuno-
deficiency virus and acquired immune deficiency
syndrome (HIV/AIDS) is increasingly recognized
and accepted by patients. Recent research findings
on the benefits of Chinese herbal medicine on
long-term survival in patients with HIV/AIDS are en-
couraging and hopeful, but inconclusive. More re-
search is needed.
© 2016 JTCM. All rights reserved.
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To date, acquired immune deficiency syndrome
(AIDS) remains a fatal disease with limited therapeutic
options. In the past 30 years it has claimed the lives of
millions, mostly in developing countries, and is the
leading cause of infection-related death in many coun-
tries. Thus, survival rates are an important indicator in
evaluating the long-term curative effect of treatments
on the disease.
In China, numerous infectious diseases [such as severe
acute respiratory syndrome (SARS, influenza A virus
subtype H1N1, encephalitis, and hepatitis] have been
successfully treated with TCM, together with a variety
of other clinical measures. According to the theory be-
hind TCM, AIDS is an infectious disease in which the
invasive pathogen causes an imbalance of yin and yang
and disharmony of internal pathophysiological func-
tion and external natural environment. TCM has been
used to treat AIDS for many years, and its effectiveness
has been demonstrated, with surrogate outcome mea-
sures such as reducing HIV viral load, increasing CD4
counts, improving immunity, ameliorating symptoms
and signs, improving the health-related quality of life
and counteracting the effects of anti-retroviral drugs.1-3
But few reports, especially long-term studies, on the
survival rates of TCM-treated AIDS patients are pub-
lished. Following a literature review on TCM treat-
ment of human immunodeficiency virus and AIDS
(HIV/AIDS), we believe that patients can benefit from
TCM, with improvement in survival rates. The main
reasons are as follows:
First, HIV is a chronic condition with a long incuba-
tion period before AIDS presents, making early treat-
ment vital to improve survival rates. Because the effica-
cy of combination antiretroviral therapy (cART) is
compromised by its risk of side-effects and drug resis-
tance, TCM has a role in treating those patients in
whom cART is no longer an option.
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Second, TCM embraces the holistic approach. Chinese
medicine practitioners often treat patients using highly
individualized interventions such as adjusting the bal-
ance of "Yin" and "Yang" and harmonizing the internal
pathophysiological function and external natural envi-
ronment changes by combining empathy and psycho-
logical counseling. Consequently, survival rates may im-
prove. In addition, TCM has also been used as adjunc-
tive therapy in some fatal diseases such as cancer, in
which it has been suggested to lower the risk of death.4
Other benefits of TCM that could prolong survival in-
clude the inhibitory activity of many Chinese herbs
against HIV activity,5 the lower cost of TCM as com-
pared with conventional medicine,6 and the positive
immunoregulatory effect of TCM.7,8
Last, in the absence of suitable methodology to verify
the curative effect of TCM in the laboratory, the evi-
dence on survival rates in patients with HIV can be ex-
trapolated from clinical research. But in the past few
decades, little research has been conducted in this re-
gard, and wherever present, studies are of poor quality,
based on small sample sizes, with limited follow-up. Re-
cently, a few studies have shown encouraging and hope-
ful trends. For example, in a cohort of 11 385 patients
with AIDS, in which 165 patients received Chinese
herbal medicine (CHM) as a 16-herb formula for 14
days to 9 months, the 8-year survival rate was 87% in
CHM users and 34% in CHM nonusers [increased sur-
vival probability for CHM user, 9.6; 95% confidence
interval (6.0, 15.4); P < 0.0001]. There were no deaths
in patients who received CHM for 6 to 9 months fol-
lowing treatment and no survivors experienced severe
adverse events, or progression of the disease. These re-
sults show that CHM may be beneficial in improving
long-term survival in patients with AIDS. However,
there were some shortfalls in this study, e.g. sampling
methods were not clearly described, and the difference
in the effect of confounders (such as cART use, CD4
counts, HIV plasma loads, complications, psychologi-
cal states, and family income at baseline), between
CHM users and non-users were not adequately consid-
ered. In another study10 comprising 1666 people living
with HIV (PLHIV), and 102 591 person-months of
follow up, 312 (18.7%) patients died in 6 years. The
total mortality rate over the study period was 3.6 per
100 person-years, which was lower than global rates.11
But being a retrospective study, the main criticism was
the absence of a control group, which discounts the
conclusion that TCM could increase survival rates and
lengthen life span in PLHIV.
In conclusion, Chinese herbal medicine may improve
the long-term survival of patients with HIV/AIDS, but
more robust research using multicenter, double-blind,
randomized, controlled studies are required.
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